Have your own idea? Try our Stock Screener
UPDATED Feb 21, 2025
Discover Belgian Pharmaceuticals & Biotech Growth Stocks that are on the BEL20. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ARGX | €619.20 | 1.9% | 64.0% | €37.6b | €632.14 | PS20.6x | E41.6% | n/a | ||
HYL | €5.28 | 0.4% | -55.3% | €147.8m | €11.10 | PS21.3x | E40.5% | n/a | ||
UCB | €181.80 | 0.7% | 88.6% | €34.5b | €201.24 | PE143.7x | E28.4% | 0.7% | ||
CYAD | €0.57 | 39.1% | 58.6% | €23.7m | n/a | PS328.6x | n/a | n/a | ||
ALEMS | €6.58 | 6.1% | -15.0% | €27.8m | n/a | PB2.7x | n/a | n/a | ||
OXUR | €0.20 | -4.8% | -93.3% | €727.7k | n/a | PS8.7x | n/a | n/a | ||
TUB | €143.40 | -2.2% | 80.8% | €6.4b | €175.00 | PE70.9x | n/a | 0.7% | ||
BIOS | €0.0044 | 2.3% | -83.9% | €2.1m | n/a | PE-0.3x | n/a | n/a |